Search - tctmd.com

Displaying 521 - 540 of 1458

Sort: Relevancy | Date

Presentation TVT 2019

OPTIMUM TAV First-In-Human Results

Presenter: Mathew Williams

June 13, 2019

Presentation TVT 2019

Occurrence of Left Ventricular Reverse Remodeling After Transcatheter Aortic Valve Replacement: Analysis of a Brazilian Cohort

Presenter: Fabiula Azevedo

June 13, 2019

Presentation TVT 2019

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

Feasibility of Repeat Transcatheter Aortic Valve Replacement (TAVR) After Sapien 3 TAVR (TAV-in-TAV): A Pilot Angiographic Study

Presenter: Gilbert Tang

June 13, 2019

Presentation TVT 2019

Diabetes Mellitus: Is There a True Paradoxical Clinical Outcome After AVR?

Presenter: Rashad Belin

June 13, 2019

Presentation TVT 2019

Acute Kidney Injury After Transcatheter Aortic Valve Replacement Is a Strong Predictor of Intermediate but Not Long-Term Mortality: Observations From Michigan Transcatheter Aortic Valve Replacement (MITAVR) Registry

Presenter: Sarah Gualano

June 13, 2019

Presentation TVT 2019

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Presenter: Vinod Thourani

June 13, 2019

Presentation TVT 2019

Rationalizing the Cost Effectiveness of Cerebral Protection During TAVR

Presenter: Hemal Gada

June 13, 2019

Presentation TVT 2019

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Presenter: Tamim Nazif

June 13, 2019

Presentation TVT 2019

The PARTNER 3 Low-Risk Randomized Trial

Presenter: Susheel Kodali

June 13, 2019

Presentation TVT 2019

The Evolut Low-Risk Randomized Trial

Presenter: Steven Yakubov

June 13, 2019

Presentation TVT 2019

When it Pops Out: Restart All Over Again From the Beginning?

Presenter: Takehiro Yamashita

June 13, 2019

Presentation TVT 2019

Ventricular Septal Defect Associated With Bioprosthetic Valve Fracturing

Presenter: Albert Chan

June 13, 2019

Presentation TVT 2019

Valve Embolization: From One Complication to Another

Presenter: Itshac Itsik Ben-dor

June 13, 2019

Presentation TVT 2019

Updates on SAPIEN Balloon-Expandable VIV

Presenter: John Webb

June 13, 2019

Presentation TVT 2019

Updates From the CoreValve and EVOLUT R Aortic VIV Registries

Presenter: Jeffrey Popma

June 13, 2019

Presentation TVT 2019

Successful BASILICA for a Failed CoreValve

Presenter: Ikki Komatsu

June 13, 2019

Presentation TVT 2019

Status Updates on the Next Generation of Cerebral Protection Devices

Presenter: Giora Weisz

June 13, 2019

Presentation TVT 2019

Splitting Leaflets. BASILICA to Reduce the Risk of Coronary Obstruction During VIV (and Other TAVR) Procedures

Presenter: Danny Dvir

June 13, 2019

Presentation TVT 2019

Severe AR After TAVI: A Unique Treatment Option

Presenter: Praveen Chandra

June 13, 2019

Advertisement

OPTIMUM TAV First-In-Human Results

Occurrence of Left Ventricular Reverse Remodeling After Transcatheter Aortic Valve Replacement: Analysis of a Brazilian Cohort

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Feasibility of Repeat Transcatheter Aortic Valve Replacement (TAVR) After Sapien 3 TAVR (TAV-in-TAV): A Pilot Angiographic Study

Diabetes Mellitus: Is There a True Paradoxical Clinical Outcome After AVR?

Acute Kidney Injury After Transcatheter Aortic Valve Replacement Is a Strong Predictor of Intermediate but Not Long-Term Mortality: Observations From Michigan Transcatheter Aortic Valve Replacement (MITAVR) Registry

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Rationalizing the Cost Effectiveness of Cerebral Protection During TAVR

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

The PARTNER 3 Low-Risk Randomized Trial

The Evolut Low-Risk Randomized Trial

When it Pops Out: Restart All Over Again From the Beginning?

Ventricular Septal Defect Associated With Bioprosthetic Valve Fracturing

Valve Embolization: From One Complication to Another

Updates on SAPIEN Balloon-Expandable VIV

Updates From the CoreValve and EVOLUT R Aortic VIV Registries

Successful BASILICA for a Failed CoreValve

Status Updates on the Next Generation of Cerebral Protection Devices

Splitting Leaflets. BASILICA to Reduce the Risk of Coronary Obstruction During VIV (and Other TAVR) Procedures

Severe AR After TAVI: A Unique Treatment Option

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content